[English] 日本語
Yorodumi- EMDB-48430: SPA of purified HIV-1 CA protein in vitro assembled with IP6 (mat... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | SPA of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. | |||||||||||||||
Map data | Refine 3D map of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. Determined via SPA. | |||||||||||||||
Sample |
| |||||||||||||||
Keywords | HIV / Mature / VLP / Lenacapavir / VIRUS LIKE PARTICLE | |||||||||||||||
| Function / homology | Function and homology informationviral budding via host ESCRT complex / ISG15 antiviral mechanism / host multivesicular body / viral nucleocapsid / viral translational frameshifting / host cell plasma membrane / host cell nucleus / virion membrane / structural molecule activity / RNA binding / zinc ion binding Similarity search - Function | |||||||||||||||
| Biological species | Human immunodeficiency virus type 1 BH10 / ![]() HIV-1 (virus) | |||||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.5 Å | |||||||||||||||
Authors | Ricana CL / Dick RA | |||||||||||||||
| Funding support | United States, 4 items
| |||||||||||||||
Citation | Journal: bioRxiv / Year: 2026Title: Lenacapavir prevents production of infectious HIV-1 by abrogating immature virus assembly. Authors: Clifton L Ricaña / Savannah G Brancato / Carolyn M Highland / Fatemeh Ekbataniamiri / Krisztina Ambrus / Juan S Rey / Mia Faerch / Bruce E Torbett / Juan R Perilla / Robert A Dick / ![]() Abstract: The HIV-1 capsid effector Lenacapavir (LEN) acts by disrupting the early (reverse transcription and nuclear entry) and late (assembly and maturation) stages of the viral lifecycle. The early stage ...The HIV-1 capsid effector Lenacapavir (LEN) acts by disrupting the early (reverse transcription and nuclear entry) and late (assembly and maturation) stages of the viral lifecycle. The early stage requires an intact Capsid consisting of a lattice of capsid protein (CA) hexamers and pentamers. Phenylalanine-Glycine (FG) containing nuclear pore proteins interact with Capsid hexamers at their FG pockets, facilitating nuclear entry. Disruption of Capsid lattice stability, or competitive binding to the FG pocket, by LEN blocks infection. Here, we provide insight into the effects of LEN on the late stage. Using a combination of cryo-EM structure determination, assembly, and viral assays, we determined that treatment of producer cells with LEN abrogates the production of infectious virus via multiple mechanisms. Previous studies have shown that HIV-1 produced from LEN treated cells have improperly formed Capsids. However, how LEN interacts with the CA domain of the Gag polyprotein during assembly, prior to maturation, is unclear. Using a viral protease (PR) defective HIV-1 clone, which traps the Gag lattice in an immature state, we found that LEN dramatically remodulates the CA domain. The resulting CA layer was mature-like despite the absence of PR cleavage. We dubbed this unnatural state as "premature" lattice. Proper immature and mature lattice formation requires inositol hexakisphosphate (IP6), but our cryo-EM work revealed a lack of IP6 in the premature lattice. These findings provide insight into the mechanisms by which LEN prevents infectious HIV-1 production. | |||||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_48430.map.gz | 161 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-48430-v30.xml emd-48430.xml | 33.7 KB 33.7 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_48430_fsc.xml | 12.8 KB | Display | FSC data file |
| Images | emd_48430.png | 127.7 KB | ||
| Masks | emd_48430_msk_1.map | 178 MB | Mask map | |
| Filedesc metadata | emd-48430.cif.gz | 8.4 KB | ||
| Others | emd_48430_additional_1.map.gz emd_48430_half_map_1.map.gz emd_48430_half_map_2.map.gz | 19 MB 139.1 MB 139 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-48430 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-48430 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9mnmMC M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_48430.map.gz / Format: CCP4 / Size: 178 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Refine 3D map of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. Determined via SPA. | ||||||||||||||||||||
| Voxel size | X=Y=Z: 0.822 Å | ||||||||||||||||||||
| Density |
| ||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Mask #1
| File | emd_48430_msk_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Additional map: Postprocess map of purified HIV-1 CA protein in...
| File | emd_48430_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Postprocess map of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. Determined via SPA. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Refine 3D half2 map of purified HIV-1 CA...
| File | emd_48430_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Refine 3D half2 map of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. Determined via SPA. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Refine 3D half1 map of purified HIV-1 CA...
| File | emd_48430_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Refine 3D half1 map of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. Determined via SPA. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : HIV-1
| Entire | Name: ![]() HIV-1 (virus) |
|---|---|
| Components |
|
-Supramolecule #1: HIV-1
| Supramolecule | Name: HIV-1 / type: virus / ID: 1 / Parent: 0 / Macromolecule list: #1 Details: Purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly. NCBI-ID: 11698 / Sci species name: HIV-1 / Sci species strain: BH10 / Virus type: VIRUS-LIKE PARTICLE / Virus isolate: STRAIN / Virus enveloped: No / Virus empty: Yes |
|---|---|
| Host (natural) | Organism: Homo sapiens (human) |
| Virus shell | Shell ID: 1 / Name: Capsid / Diameter: 1000.0 Å |
-Macromolecule #1: HIV-1 CA
| Macromolecule | Name: HIV-1 CA / type: protein_or_peptide / ID: 1 / Number of copies: 4 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Human immunodeficiency virus type 1 BH10 / Strain: BH10 |
| Molecular weight | Theoretical: 25.630426 KDa |
| Recombinant expression | Organism: ![]() |
| Sequence | String: PIVQNLQGQM VHQAISPRTL NAWVKVVEEK AFSPEVIPMF SALSEGATPQ DLNTMLNTVG GHQAAMQMLK ETINEEAAEW DRLHPVHAG PIAPGQMREP RGSDIAGTTS TLQEQIGWMT HNPPIPVGEI YKRWIILGLN KIVRMYSPTS ILDIRQGPKE P FRDYVDRF ...String: PIVQNLQGQM VHQAISPRTL NAWVKVVEEK AFSPEVIPMF SALSEGATPQ DLNTMLNTVG GHQAAMQMLK ETINEEAAEW DRLHPVHAG PIAPGQMREP RGSDIAGTTS TLQEQIGWMT HNPPIPVGEI YKRWIILGLN KIVRMYSPTS ILDIRQGPKE P FRDYVDRF YKTLRAEQAS QEVKNWMTET LLVQNANPDC KTILKALGPG ATLEEMMTAC QGVGGPGHKA RVL UniProtKB: Gag polyprotein |
-Macromolecule #2: Lenacapavir
| Macromolecule | Name: Lenacapavir / type: ligand / ID: 2 / Number of copies: 3 / Formula: QNG |
|---|---|
| Molecular weight | Theoretical: 968.282 Da |
-Macromolecule #3: INOSITOL HEXAKISPHOSPHATE
| Macromolecule | Name: INOSITOL HEXAKISPHOSPHATE / type: ligand / ID: 3 / Number of copies: 2 / Formula: IHP |
|---|---|
| Molecular weight | Theoretical: 660.035 Da |
| Chemical component information | ![]() ChemComp-IHP: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 13 mg/mL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 6.2 Component:
Details: 25 mM MES, 2mM TCEP, 500 uM LEN | ||||||||||||
| Grid | Model: Quantifoil R2/2 / Material: GOLD / Mesh: 300 / Support film - Material: CARBON / Support film - topology: HOLEY / Support film - Film thickness: 120 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 45 sec. / Pretreatment - Atmosphere: AIR / Pretreatment - Pressure: 0.027 kPa Details: Vacuum held for 30 sec before 20 mA were applied for 45 sec. | ||||||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 90 % / Chamber temperature: 279 K / Instrument: LEICA EM GP | ||||||||||||
| Details | Purified HIV-1 CASPNC protein in vitro assembled with IP6 (immature morphology). 500 uM LEN was added post assembly. |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Temperature | Min: 93.15 K / Max: 103.15 K |
| Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
| Details | Preliminary grid screening was performed manually. |
| Image recording | Film or detector model: GATAN K3 BIOCONTINUUM (6k x 4k) / Digitization - Dimensions - Width: 11520 pixel / Digitization - Dimensions - Height: 8184 pixel / Number grids imaged: 1 / Number real images: 7510 / Average exposure time: 1.731 sec. / Average electron dose: 50.0 e/Å2 Details: Images were collected in movie-mode with 50 frames per image at a total dose of 50 e-/A2. |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 70.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.4 µm / Nominal defocus min: 0.4 µm / Nominal magnification: 105000 |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
+
Image processing
-Atomic model buiding 1
| Initial model | PDB ID: Chain - Source name: PDB / Chain - Initial model type: experimental model |
|---|---|
| Details | Molecular dynamics flexible fitting was done using NAMD targeting cross-correlation coefficients. |
| Refinement | Space: REAL / Protocol: FLEXIBLE FIT / Target criteria: Cross-correlation coefficient |
| Output model | ![]() PDB-9mnm: |
Movie
Controller
About Yorodumi




HIV-1 (virus)
Keywords
Authors
United States, 4 items
Citation


Z
Y
X

































Homo sapiens (human)

FIELD EMISSION GUN

